Markus Heinrich

Prof. Dr. Markus Heinrich is an Associate Professor (W2) of Pharmaceutical Chemistry at the Department of Chemistry and Pharmacy, Friedrich-Alexander-University Erlangen-Nuremberg (FAU). He leads the Heinrich Laboratory, focusing on radical chemistry, drug synthesis, and functionalization methods. His research spans organic chemistry, medicinal chemistry, and materials science, with applications in drug development, nanotechnology, and sustainable processes.

Education:

• Ph.D. in Organic Chemistry (2003), Ludwig-Maximilians-University Munich
• Habilitation in Organic Chemistry (2009), Technical University of Munich

Research Interests:
Heinrich's work emphasizes radical-based methodologies for drug synthesis, including arylation reactions, fluorination, and late-stage functionalization of APIs. His lab explores applications in medicinal chemistry (e.g., dopamine receptors, GPCRs), nanomaterials (graphene functionalization), and industrial processes. Notable specialties include Meerwein arylation, titanium-mediated reactions, and photochemical catalysis.

Recent Article Trends:
Publications highlight advances in radical chemistry (e.g., fluorination under visible light), graphene functionalization, and drug design targeting dopamine receptors and viral signaling pathways (e.g., US28 receptor of human cytomegalovirus).

Awards:

• Liebig Fellowship (Chemical Industry Fund)
• ADUC Annual Prize for Habilitands (2008)

Advising & Grants:

• Supervised over 40 Ph.D./Master students and apprentices since 2009.
• Collaborates with institutions like UC Irvine (Overman group) and industry partners (e.g., Sandoz).
• Active in funding programs (e.g., European Research Council, DFG).

Labs & Teams:
Heinrich Laboratory at FAU hosts interdisciplinary teams working on radical chemistry, medicinal synthesis, and materials science. Key projects include development of fluorinated drug candidates and graphene-based nanomaterials.